Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients

Autor: Mezzabotta, L., Vanni, Ester, Rosso, Chiara, Carenzi, S., Gambino, Roberto, Gaggini, M., Lucarelli, D., Faletti, Riccardo, Cassader, Maurizio, Smedile, Antonina, Rizzetto, Mario, Gastaldelli, A., Bugianesi, Elisabetta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3ed8b56956b22e1b2b5680ba482529bc
http://hdl.handle.net/2318/131634

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

Autor: Pegbeliver, Study Group, Colombo, M, Facchetti, F, Massetto, B, Regep, L, Iannacone, C, Giuberti, T, Fargion, S, Farci, P, Boninsegna, S, Di Marco, V, Fasano, M, Sagnelli, E, Di Costanzo, Gg, Viganò, M, Lampertico, P, Andreone, P, Riili, A, Scuteri, A, Cursaro, C, Andriulli, A, Niro, Ga, Angarano, G, Santantonio, Ta, Palattella, Ms, Brunetto, MAURIZIA ROSSANA, Colombatto, P, Coco, B, Ciccorossi, P, Oliveri, F, Sacco, R, Bruno, S, Bollani, S, Chiesa, A, Carosi, G, Baiguera, C, Rossi, S, Zaltron, S, Puoti, M, Cozzolongo, R, Giannuzzi, V, Craxì, A, Calvaruso, V, Venezia, G, Lanza, Ag, Di Perri, G, Cariti, G, Mollaretti, O, De Blasi, T, Kulmiye, C, Rostagno, R, Lai, Me, Serra, G, Chessa, L, Balestrieri, C, Cauli, C, Fargion, Sr, Bertelli, C, Fatta, E, Fattovich, G, Pasino, M, Zanni, S, Olivari, N, Zagni, I, Ferrari, C, Schivazappa, S, Laccabue, D, Penna, A, Gaeta, G, Stanzione, M, Stornaiuolo, G, Martines, D, Raimondo, G, Caccamo, G, Squadrito, G, Isgrò, G, Rizzetto, M, Lagget, M, Carenzi, S, Ruggiero, G, Marrone, A, Messina, V, Di Caprio, Du, Selva, V, Toniutto, P.

Treatment with peginterferon α-2a (PegIFN) for 48 weeks is the standard of care for selected HBeAg-negative patients chronically infected with hepatitis B virus (HBV), but with limited treatment efficacy. A study was undertaken to investigate whethe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dee5413b7f9c6cb0e810d621c76720f
http://hdl.handle.net/11568/844307

Peripheral insulin resistance rather than hepatic is a primary defect in non obese, non diabetic, non dyslipidemic nafld patients: correlation with liver damage

Autor: Mezzabotta, L., Bugianesi, Elisabetta, Salamone, F., Rosso, Chiara, Gaggini, M., Buzzigoli, E., Saba, F., Carenzi, S., Caviglia, GIAN PAOLO, Gambino, Roberto, Cassader, Maurizio, Gastaldelli, A.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::909141b65015b000218188ecc4909615
http://hdl.handle.net/2318/103230

P1028 NON-INVASIVE SCORE SYSTEM FOR FIBROSIS (NISF) IN CHRONIC LIVER DISEASE: A NEW MODEL COMBINING BIOCHEMICAL, ELASTOGRAPHIC AND ULTRASOUND DATA

Autor: Gaia, S., Campion, D., Spandre, M., Cantamessa, A., Brunello, F., Evangelista, A., Cosso, L., Carucci, P., Rolle, E., Ciccone, G., Bugianesi, E., Carenzi, S., Rizzetto, M.

Publikováno v: In Journal of Hepatology April 2014 60(1) Supplement:S417-S417

P843 ALTERATION IN GLUCOSE METABOLISM AFTER AN ORAL GLUCOSE LOAD AND RELATIONSHIP WITH LIVER DAMAGE IN PATIENTS WITH NAFLD

Autor: Vanni, E., Mezzabotta, L., Rosso, C., Gaggini, M., Gambino, R., Salomone, F., Buzzigoli, E., Saponaro, C., Saba, F., Ciociaro, D., Caviglia, G.P., Abate, M.L., Carenzi, S., Smedile, A., Rizzetto, M., Cassader, M., Gastaldelli, A., Bugianesi, E.

Publikováno v: In Journal of Hepatology April 2014 60(1) Supplement:S352-S353